TIAA Trust National Association Sells 6,102 Shares of CVS Health Co. (NYSE:CVS)

TIAA Trust National Association trimmed its stake in CVS Health Co. (NYSE:CVSFree Report) by 13.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 40,475 shares of the pharmacy operator’s stock after selling 6,102 shares during the period. TIAA Trust National Association’s holdings in CVS Health were worth $3,196,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Bryn Mawr Capital Management LLC increased its position in CVS Health by 74.0% in the 3rd quarter. Bryn Mawr Capital Management LLC now owns 43,213 shares of the pharmacy operator’s stock worth $3,017,000 after buying an additional 18,385 shares during the period. Value Partners Investments Inc. increased its position in CVS Health by 26.5% in the 3rd quarter. Value Partners Investments Inc. now owns 991,601 shares of the pharmacy operator’s stock worth $69,261,000 after buying an additional 207,702 shares during the period. Sonora Investment Management Group LLC increased its position in CVS Health by 1.6% in the 3rd quarter. Sonora Investment Management Group LLC now owns 50,488 shares of the pharmacy operator’s stock worth $3,525,000 after buying an additional 774 shares during the period. Checchi Capital Advisers LLC increased its position in CVS Health by 2.3% in the 3rd quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator’s stock worth $726,000 after buying an additional 233 shares during the period. Finally, Personal CFO Solutions LLC increased its position in CVS Health by 2.6% in the 3rd quarter. Personal CFO Solutions LLC now owns 19,355 shares of the pharmacy operator’s stock worth $1,351,000 after buying an additional 491 shares during the period. 80.66% of the stock is owned by institutional investors.

CVS Health Price Performance

Shares of CVS stock opened at $73.82 on Wednesday. The stock’s fifty day simple moving average is $76.02 and its 200 day simple moving average is $73.70. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. The firm has a market cap of $92.90 billion, a price-to-earnings ratio of 11.43, a P/E/G ratio of 1.05 and a beta of 0.52. CVS Health Co. has a one year low of $64.41 and a one year high of $83.25.

CVS Health (NYSE:CVSGet Free Report) last announced its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, beating the consensus estimate of $2.01 by $0.11. The business had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. CVS Health’s quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.99 EPS. On average, analysts expect that CVS Health Co. will post 8.33 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.60%. The ex-dividend date is Friday, April 19th. CVS Health’s dividend payout ratio is currently 41.18%.

Analysts Set New Price Targets

CVS has been the topic of several recent analyst reports. Leerink Partnrs reaffirmed an “outperform” rating on shares of CVS Health in a research report on Monday, February 26th. Piper Sandler lifted their price target on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, March 15th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $87.00 price target on shares of CVS Health in a research report on Thursday, February 8th. StockNews.com lowered CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Finally, HSBC initiated coverage on CVS Health in a report on Friday, December 22nd. They set a “buy” rating and a $94.00 price objective on the stock. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and a consensus target price of $89.44.

Read Our Latest Stock Report on CVS Health

Insiders Place Their Bets

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.25% of the company’s stock.

CVS Health Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Recommended Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.